Table 1 Physical characteristics, clinical history, and current psychological drug used for therapy in individual subjects.
Subject No. | Age, yr | Height, cm | BMI, kg/m2 | Clinical history of depression, mo | Psychotropic drugs |
|---|---|---|---|---|---|
1 | 58 | 159.9 | 16.8 | 31 | Ethyl loflazepate |
2 | 42 | 151.4 | 24.0 | 36 | Paroxetine, Ethyl loflazepate, Rilmazafone |
3 | 47 | 155.1 | 30.5 | 55 | Paroxetine, Trazodone, Bromazepam, Zopiclone |
4 | 61 | 159.7 | 24.0 | 4 | Ethyl loflazepate |
5 | 65 | 154.1 | 16.8 | 24 | Ethyl loflazepate |
6 | 52 | 154.8 | 29.4 | 48 | Fluvoxamine, Trazodone, Bromazepam, Zolpidem |
7 | 42 | 166.5 | 37.2 | 36 | Paroxetine, Mirtazapine, Trazodone, Sulpiride, Ethyl loflazepate, Zolpidem |
8 | 55 | 158.1 | 22.9 | 54 | Sertraline, Zolpidem |
9 | 56 | 154.2 | 23.3 | 30 | Duloxetine, Ethyl loflazepate, Lorazepam, Clonazepam, Pregabalin, Brotizolam |
Mean ± SD | 53 ± 8 | 157.1 ± 4.5 | 25.0 ± 6.5 | 35 ± 16 |
